Teva Pharmaceutical Industries (TEVA) Balance Sheet: Assets & Liabilities

Teva Pharmaceutical Industries (TEVA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Teva Pharmaceutical Industries reported total assets of $40.76B and total liabilities of $32.84B. Shareholders' equity was $7.91B, up 47.2% from $5.37B a year earlier. Total debt stood at $17.09B against $3.56B in cash and short-term investments, a net debt position of $13.54B. That puts debt-to-equity at 2.16, compared with 3.38 a year earlier.

Teva Pharmaceutical Industries Balance Sheet Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Teva Pharmaceutical Industries Limited (TEVA) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	3.56	3.30	3.23	2.80	2.17	2.18	1.98	1.78	0.96
Cash & Short-Term Investments	3.56	3.30	3.23	2.80	2.17	2.18	1.98	1.78	0.96
Accounts Receivable	3.71	3.06	3.41	3.70	4.53	4.58	5.68	5.82	7.13
Inventory	3.18	3.01	4.02	3.83	3.82	4.40	4.42	4.73	4.92
Other Current Assets	3.50	3.19	1.83	0.55	2.06	1.84	1.39	1.46	2.35
Total Current Assets	13.95	12.55	12.49	12.05	12.57	13.01	13.46	13.79	15.38
Non-Current Assets
Property, Plant & Equipment (Net)	4.43	4.95	6.15	6.16	6.48	6.85	6.95	6.87	7.67
Long-Term Investments	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.08
Goodwill	16.00	15.15	17.18	17.63	20.04	20.62	24.85	24.92	28.41
Intangible Assets	3.78	4.42	5.39	6.27	7.47	8.92	11.23	14.01	17.64
Other Non-Current Assets	0.41	0.46	2.28	0.44	0.52	0.54	0.59	0.73	0.85
Total Non-Current Assets	26.81	26.77	30.99	31.96	35.09	37.63	44.01	46.89	55.23
Total Assets	40.76	39.33	43.48	44.01	47.67	50.64	57.47	60.68	70.62
Current Liabilities
Accounts Payable	2.53	2.20	2.60	1.89	1.69	1.76	1.72	1.85	2.07
Short-Term Debt	1.82	1.87	1.67	2.11	1.54	3.30	2.46	2.22	3.65
Current Portion of Long-Term Debt	1.82	1.78	1.67	2.11	1.43	-	-	-	-
Accrued Liabilities	7.57	7.09	6.92	2.15	7.01	-	-	-	-
Deferred Revenue	0.00	0.00	0.00	6.47	7.01	7.29	8.72	9.45	11.44
Other Current Liabilities	9.11	8.73	1.06	1.01	7.81	8.10	9.49	10.25	12.21
Total Current Liabilities	13.46	12.80	12.25	11.47	11.03	13.16	13.67	14.32	17.92
Non-Current Liabilities
Long-Term Debt	15.27	16.30	18.16	19.10	22.06	23.23	25.00	26.70	28.83
Deferred Tax Liabilities	0.30	0.48	0.61	0.55	0.78	0.96	1.10	2.14	3.28
Other Non-Current Liabilities	3.81	4.03	4.63	3.94	3.34	0.94	3.74	3.87	5.12
Total Non-Current Liabilities	19.38	20.81	23.11	23.94	25.40	26.42	28.73	30.57	33.95
Total Liabilities	32.84	33.61	35.35	35.41	36.42	39.58	42.41	44.89	51.87
Stockholders' Equity
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.05
Retained Earnings	-13.76	-15.17	-13.53	-12.98	-10.53	-10.95	-6.96	-5.96	-3.80
Accumulated Other Comprehensive Income	-2.39	-3.15	-2.70	-2.84	-2.68	-2.40	-2.31	-2.46	-1.85
Treasury Stock	4.13	4.13	4.13	4.13	-	-	-	-	-
Additional Paid-in Capital	24.01	23.64	23.68	27.69	23.43	23.31	23.18	23.07	19.33
Minority Interest	0.00	0.35	0.62	0.79	0.97	1.04	1.09	1.09	1.39
Shares Outstanding	1.15	1.13	1.12	1.11	-	-	-	-	-
Total Stockholders' Equity	7.91	5.37	8.13	7.80	10.28	10.03	13.97	14.71	17.36
Total Liabilities & Equity	40.75	39.33	43.48	44.01	47.67	50.64	57.47	60.68	70.62

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Teva Pharmaceutical Industries Balance Sheet

How much debt does Teva Pharmaceutical Industries have?

Teva Pharmaceutical Industries had total debt of $17.09B as of Dec 31, 2025, against $3.56B in cash and short-term investments. Its debt-to-equity ratio was 2.16. Total debt was $18.17B a year earlier.

What are Teva Pharmaceutical Industries's total assets?

Teva Pharmaceutical Industries reported total assets of $40.76B as of Dec 31, 2025, up 3.6% from $39.33B a year earlier. Total liabilities were $32.84B.

What is Teva Pharmaceutical Industries's shareholders' equity?

Teva Pharmaceutical Industries's shareholders' equity was $7.91B as of Dec 31, 2025, or about $6.88 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition